药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Natamycin
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Deutetrabenazine.
Natamycin
Glasdegib
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Glasdegib.
Natamycin
Lumefantrine
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Lumefantrine.
Natamycin
Artemether
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Artemether.
Natamycin
Asenapine
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Asenapine.
Natamycin
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Tetrabenazine.
Natamycin
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Zuclopenthixol.
Natamycin
Temafloxacin
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Temafloxacin.
Natamycin
Lithium cation
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Lithium cation.
Natamycin
Paliperidone
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Paliperidone.
Natamycin
Bepridil
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Bepridil.
Natamycin
Halofantrine
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Halofantrine.
Natamycin
Ziconotide
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Ziconotide.
Natamycin
Dexniguldipine
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Dexniguldipine.
Natamycin
Tetrandrine
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Tetrandrine.
Natamycin
Lomerizine
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Lomerizine.
Natamycin
Emopamil
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Emopamil.
Natamycin
Dexverapamil
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Dexverapamil.
Natamycin
Fish oil
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Fish oil.
Natamycin
WIN 55212-2
The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with WIN 55212-2.